Google News

Data from the Phase 1 CARLYSLE study in severe refractory systemic lupus erythematosus (srSLE) suggests obe-cel is well tolerated with […]

Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual …

(NASDAQ: TNXP) presented clinical trial data for its fibromyalgia treatment Tonmya at the 2025 American College of Rheumatology Convergence in

… Rheumatology (ACR) Convergence, held October 24–29, 2025, in Chicago … Rheumatology criteria for fibromyalgia. Treatment with Tonmya …

Kymera Therapeutics (NASDAQ: KYMR) presented new preclinical data for KT-579, an oral IRF5 degrader, at the American College of Rheumatology

We collected audit data from patients aged 16 years and older who attended specialist rheumatology centres in England and Wales

… Rheumatology (ACR) Convergence 2025, currently underway in Chicago. The featured poster highlights findings from Citryll’s Phase I clinical trial …

Hospitals and specialized rheumatology centers provide improved access to clinical care, which strengthens treatment uptake across the region. In …

For rheumatologists, these data reinforce upadacitinib’s role as a viable and durable option for patients across multiple lines of therapy,

claire-daien-md-phd. Advertisement. Claire Daien, MD, PhD. Prof of Rheumatology at Université de Montpellier. Articles by Claire Daien, MD, PhD …

We’ll explore how SPY072’s differentiated dosing profile could influence Spyre Therapeutics’ place in the competitive rheumatology pipeline. Rare …

… study because diagnostic reasoning in rheumatology is particularly complex due to the multisystem nature of rheumatic diseases and their

… rheumatology therapies. The new guidelines include three strong recommendations: Taper prednisone dose to <5 mg daily within six months,;

Patients prescribed opioids to relieve pain associated with rheumatic disease may not always experience a benefit as it has been

Eric F. Morand, MD, can be reached at eric.morand@monash.edu. Published by: healio rheumatology logo. Sources/Disclosures. Source: Morand E …

Affiliations. 1 Research Center for Chronic Inflammatory Diseases, Tehran University of Medical Sciences, Tehran, Iran. 2 Rheumatology Research …

Eunice Vial, a rheumatology specialist at Northampton General Hospital (NGH), used annual leave to complete a 16-day visit to the

… Rheumatology (ACR) Convergence 2025 in Chicago. “This promising initial clinical data demonstrates that FT819 can deliver transformative outcomes …

… Rheumatology (ACR) Convergence 2025 , held October 24–29 in Chicago, Illinois, by Lin Qiao, MD, Peking Union Medical College

… Rheumatology (ACR) Convergence 2025 in Chicago. “This promising initial clinical data demonstrates that FT819 can deliver transformative outcomes …

Monosodium Urate Crystals Dissolve at Similar Rates in Joints and Tendons, DECT Study Finds. 26 Oct 2025. Rheumatology · View

Rheumatologists are not immune to this distress, according to Shanafelt. “You have chosen to be a rheumatologist, and there are

… Rheumatology & Arthritis Learning Network or HMP Global, its employees, and affiliates. … Cytokines and the Future of Rheumatology.

… reflect the views, policy, or position of the Rheumatology & Arthritis Learning Network or HMP Global, its employees, and

… Rheumatology annual meeting (ACR Convergence 2025) to be held in … rheumatic autoimmune diseases that will be initiating clinical …

… Rheumatology (ACR) Convergence 2025, the largest global gathering of rheumatologists. Presentations will include clinical data demonstrating that …

The data will be featured in a poster presentation from Charité, University of Berlin, at the American College of Rheumatology